SCHEMBL5165045

SCHEMBL5165045

O=C(NO)OC1c2ccccc2CCN1S(=O)(=O)c1ccc(Oc2ccc(Cl)cc2)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 7/20 0.44
LIPE Q05469 1/20 0.42
MMP12 P39900 3/20 0.41
MMP8 P22894 7/20 0.41
MMP3 P08254 4/20 0.41
MMP9 P14780 6/20 0.40
MMP13 P45452 4/20 0.40
ADAM17 P78536 3/20 0.40
MMP2 P08253 4/20 0.40
MMP14 P50281 3/20 0.40
ADAMTS4 O75173 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
MMP7 P09237 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165142 1.00 MMP1 (0.44) MMP1LIPEMMP12MMP8MMP3
SCHEMBL5165889 0.93 MMP1 (0.47) MMP1MMP12MMP8MMP3MMP9
SCHEMBL5162223 0.93 MMP1 (0.47) MMP1MMP12MMP8MMP3MMP9
SCHEMBL5163767 0.93 MMP1 (0.47) MMP1MMP12MMP8MMP3MMP9
SCHEMBL5164082 0.90 MMP1 (0.48) MMP1MMP12MMP8MMP3MMP9
SCHEMBL5162618 0.90 MMP1 (0.48) MMP1MMP12MMP8MMP3MMP9
SCHEMBL5430840 0.90 MMP8 (0.42) MMP1LIPEMMP12MMP8MMP3
SCHEMBL5437373 0.90 MMP8 (0.42) MMP1LIPEMMP12MMP8MMP3
SCHEMBL5191360 0.89 MMP1 (0.42) MMP1LIPEMMP12MMP8MMP3
SCHEMBL5163191 0.89 MMP1 (0.42) MMP1LIPEMMP12MMP8MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763516-A2 SUBSTITUTED TETRAHYDROISOCHINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRAGS Sanofi-Aventis Deutschland GmbH (DE) 2007-03-21 EP disclosed
WO-2006002763-A2 SUBSTITUTED TETRAHYDROISOCHINOLINES USED IN THE FORM OF MMP INHIBITORS, METHOD FOR THE PRODUCTION AND USE THEREOF IN THE FORM OF DRAGS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-01-12 WO disclosed